Home » Stocks » BLI

Berkeley Lights, Inc. (BLI)

Stock Price: $83.75 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $83.66 -0.09 (-0.11%) Jan 15, 7:41 PM
Market Cap 5.39B
Revenue (ttm) 59.18M
Net Income (ttm) -32.92M
Shares Out 53.60M
EPS (ttm) -0.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $83.75
Previous Close $83.75
Change ($) 0.00
Change (%) 0.00%
Day's Open 85.84
Day's Range 82.65 - 90.09
Day's Volume 1,415,165
52-Week Range 56.00 - 106.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 6 days ago

EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Pla...

GlobeNewsWire - 1 week ago

EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming 3...

Zacks Investment Research - 4 weeks ago

Berkeley Lights (BLI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

GlobeNewsWire - 1 month ago

EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,...

GlobeNewsWire - 2 months ago

EMERYVILLE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the launch of a public offering of 3,000,000 shares of common sto...

Seeking Alpha - 2 months ago

Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

EMERYVILLE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended September 30...

GlobeNewsWire - 2 months ago

EMERYVILLE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be report financial results for th...

Forbes - 4 months ago

Eric Hobbs discusses how Berkeley Lights is not just fighting COVID-19, but also accelerating the design-build-test cycle for all of synthetic biology.

GlobeNewsWire - 4 months ago

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption...

GlobeNewsWire - 4 months ago

EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcomin...

GlobeNewsWire - 4 months ago

EMERYVILLE, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2...

GlobeNewsWire - 5 months ago

EMERYVILLE, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,3...

Market Watch - 6 months ago

Shares of Berkeley Lights Inc. BLI, +134.09% took flight Friday, as the cell biology company went public at a price that was more than double what the upsized initial public offering was priced.

Market Watch - 6 months ago

Berkeley Lights Inc. raised $178.2 million as the cell biology company's upsized initial public offering priced above the expected range.

About BLI

Berkeley Lights, a digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. It offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. The company was incorporated in 2011 and is based in Emeryville, California.

Industry
Biotechnology
IPO Date
Jul 17, 2020
CEO
Eric Hobbs
Employees
210
Stock Exchange
NASDAQ
Ticker Symbol
BLI
Full Company Profile

Financial Performance

In 2019, BLI's revenue was $56.69 million, an increase of 81.13% compared to the previous year's $31.30 million. Losses were -$18.30 million, -21.58% less than in 2018.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is 92.33, which is an increase of 10.24% from the latest price.

Price Target
$92.33
(10.24% upside)
Analyst Consensus: Buy